2018-10-02 16:23:40AMZN   - $1,970.00
-34.4 (-1.72%) , TSLA - $301.00
-9.4 (-3.03%) … 16:2310/02/18 10/0216:23 10/02/1816:23 | Fly Intel: Wall Street's top stories for TuesdayThe Dow had a second strong day after yesterday's news that the U.S. and Canada had reached an agreement that will allow for the two nations to join Mexico in a new trade pact, to be called the USMCA, that will replace the previous NAFTA deal. While the U.S. has been making progress with several allies on trade pacts, the most important trade fight remains with China, and there have been no recent headlines indicating progress on that front. While the blue chip index added another 0.5%, the Nasdaq slid by a similar percentage and the S&P closed trading nearly where it had begun. ECONOMIC EVENTS: In the U.S., no economic data of note were reported. COMPANY NEWS: Amazon (AMZN) announced plans to raise the minimum wage for all its U.S. employees to $15, effective November 1, and encouraged its "competitors and other large employers" to join in the action. The pay hike comes amid a wave of criticism from politicians, led by Senator Bernie Sanders, about the e-commerce giant's treatment of warehouse workers... Tesla (TSLA) announced that it produced 80,142 vehicles, including 53,239 Model 3 vehicles, in the third quarter and delivered 83,500 vehicles, including 55,840 Model 3s. Other automakers also issued sales reports this morning, with both Ford (F) and General Motors (GM) reporting U.S. sales declines. However, Ford's report covered only September while GM's was for the entire third quarter, as the latter no longer issues monthly sales reports... PepsiCo (PEP) shares closed about 2% lower after the snack foods and beverage giant reported better than expected quarterly results but trimmed its full-year profit forecast due to the impact of foreign exchange rates... Meanwhile, Reuters reported that Exxon Mobil (XOM) is exploring the sale of many of its U.S. Gulf of Mexico assets, as higher oil prices prompt the company to review its portfolio. MAJOR MOVERS: Among the noteworthy gainers was Clovis Oncology (CLVS), which rose 8% after the FDA granted Breakthrough Therapy designation for Rubraca for the third line treatment of patients with BRCA mutated metastatic castrate-resistant prostate cancer. Also higher was India Globalization Capital (IGC), which surged 46% despite short-seller Citron Research calling the shares a "gift" to those that can short it. Among the notable losers was Ring Energy (REI), which slid 18% after Seaport Global analyst John Aschenbeck downgraded the stock to Neutral and cut his price target on the shares to $12 from $20. Also lower was Stitch Fix (SFIX), which dropped 35% after reporting quarterly results. INDEXES: The Dow rose 122.73, or 0.46%, to 26,773.94, the Nasdaq lost 37.76, or 0.47%, to 7,999.55, and the S&P 500 declined 1.16, or 0.04%, to 2,923.43. AMZN - $1,970.00
-34.4 (-1.72%) TSLA - $301.00
-9.4 (-3.03%) F - $9.20
-0.12 (-1.29%) GM - $33.31
-0.89 (-2.60%) PEP - $108.72
-2.11 (-1.90%) XOM - $86.45
0.62 (0.72%) CLVS - $31.40
2.245 (7.70%) IGCIndia Globalization Capital - $13.13
4.11 (45.57%) - $8.71
-1.95 (-18.29%) SFIX - $28.90
-15.8 (-35.35%) | |
|---|
- $1,970.00
-34.4 (-1.72%) - 10/02/18
- LOOP
10/02/18
NO CHANGETarget $15
LOOP
Hold Bed Bath & Beyond pricing gap with Amazon narrowed in August, says Loop Capital Loop Capital analyst Anthony Chukumba kept his Hold rating and $15 price target on Bed Bath & Beyond (BBBY), saying his channel checks indicate a further narrowing of the pricing gap with Amazon (AMZN). The analyst notes the gap in August has shrunk to 13.6% on average vs. 16.9% in July, but also warns that given its position as the "most dynamic retailer" in the U.S. in terms of pricing, Amazon can "quickly and easily lower prices if top-line growth underperforms". - 10/02/18
- WELS
Amazon, eBay 'ramping their ad games,' says Wells Fargo After performing a deep-dive analysis of online retailers' opportunity in online advertising, Wells Fargo analyst Peter Stabler concludes that the effort remains in early days, with untapped ad demand among CPG advertisers, potential tailwinds from increasing ad coverage and improved ad targeting, an emerging opportunity among non-endemic advertiser categories, and ongoing development of online retailers' ad technology and supporting partner ecosystems. The analyst estimates that Amazon's (AMZN) pureplay retail ad business will generate nearly $7B of revenue this year, with other display and video ads to generate about $2B in gross revenue. Stabler argues that Amazon is well ahead of the online retail pack in terms of audience scale and engagement, ad platform development, and sales/partner execution, but is also still in the early days of penetrating its opportunity across retail. Additionally, the analyst believes eBay (EBAY) is also well positioned but may face more limited opportunity. - 10/01/18
- KEYB
Amazon represents ongoing threat to mattress industry, says KeyBanc KeyBanc analyst Bradley Thomas says that he came across several mattress models launched under the AmazonBasics brand on Amazon. While not a surprise, the analyst believes the launch warrants monitoring. Initially, Thomas thinks this line will likely take share from other lower-price online brands, rather than having an effect on the middle or upper price points. Nonetheless, the analyst believes Amazon represents an ongoing threat to most of the traditional side of the industry. - 10/02/18
- LOOP
10/02/18
NO CHANGETarget $2200
LOOP
Buy Amazon's 'savvy' wage hike to minimally impact profitability, says Loop Capital Loop Capital analyst Anthony Chukumba views the Amazon.com's announcement of a minimum wage hike to $15 per hour as a "savvy move" that should result in lower fulfillment center employee turnover. The news is a "public relations victory" for Amazon, Chukumba tells investors in a research note. Further, he believes the wage increase will have a "fairly limited" on the company's overall profitability. The analyst keeps a Buy rating on Amazon with a $2,200 price target. - $301.00
-9.4 (-3.03%) - 10/02/18
- WOLF
10/02/18
INITIATIONTarget $295
WOLF
Peer Perform Tesla initiated with a Peer Perform at Wolfe Research Wolfe Research initiated Tesla with a Peer Perform and $295 price target. - 10/01/18
- RBCM
10/01/18
NO CHANGERBCM
Sector Perform Tesla SEC settlement is a positive outcome, says RBC Capital RBC Capital analyst Joseph Spak kept his Sector Perform rating on Tesla after its CEO Elon Musk settled the SEC charges against him for $40M combined and announced his resignation as the Board chairman. The analyst says it was a positive outcome for the company as it will allow it to continue raising capital and keep Musk as the CEO. Spak adds that the outcome of splitting a CEO and chairman positions is also a sign of management "maturity", with hopes that a "true check" on Musk will emerge to bring more accountability on the company's claims and targets. - 10/02/18
- BARD
10/02/18
NO CHANGETarget $411
BARD
Outperform Tesla shares likely to move higher into Q3 report, says Baird Baird analyst Ben Kallo said he expects Tesla shares to move higher into the company's full Q3 report as he thinks its deliveries are good enough to support strong financial results. Kallo noted that average Model 3 production grew substantially from 2,198 per week in Q2 to about 4,100 per week in Q3, which he views favorably. The analyst keeps a Fresh Pick designation on Tesla shares with an Outperform rating and $411 price target. - 10/01/18
- ADAM
10/01/18
NO CHANGETarget $316
ADAM
Hold Musk's settlement with SEC 'positive' for Tesla, says Canaccord Canaccord analyst Jed Dorsheimer says he believes Elon Musk's settlement with the Securities and Exchange Commission will be "positive" for Tesla shares, as it should improve governance and allow investors to focus solely on the operations. However, the analyst believes the "distractions" have likely impacted operations and now predicts a miss in Model 3 production, at 48,000 vs. expectations of 50,000-55,000. Dorsheimer, who maintains a Hold rating and $316 price target on Tesla shares, says he would become more constructive as details of who the new chairman and independent directors might be or a significant improvement in the operations and profitability of the company. - $9.20
-0.12 (-1.29%) - 09/26/18
- LEHM
09/26/18
NO CHANGETarget $11
LEHM
Equal Weight Ford price target lowered to $11 from $12 at Barclays In a research note titled "'Going Further' isn't further enough," Barclays analyst Brian Johnson lowered his price target for Ford Motor to $11 and $12 and keeps an Equal Weight rating on the name. Likely restructuring plans are not enough to get us interested, Johnson tells investors after Ford cancelled its investor day. Ford's plan borrows ideas from other manufacturers around shifting product toward trucks, exiting unattractive geographies and rationalizing architectures, the analyst contends. He says that even if successful, he sees little earnings upside and limited potential for multiple expansion for Ford shares. - 09/19/18
- VERF
09/19/18
NO CHANGEVERF
Sell E-tron may not be 'Tesla killer,' but still a 'real risk,' says Vertical Group After attending Audi's (AUDVF) launch event for its e-tron SUV, Vertical Group analyst Gordon Johnson said he sees Audi's foray in the EV space as "a real risk" to Tesla (TSLA) and other EV auto makers including Chevy (GM) and Ford (F). The Electrify America charging network, owned by a JV of Audi parent Volkswagen (VLKAY) and funded by "Dieselgate," positions Audi's fast-charging ambitions among the most robust, if not the most robust, in the U.S. currently, added Johnson. He does not see Audi's forthcoming e-tron as a "TSLA Killer," but does not "see it a stretch to think of it as a potential TSLA Model X killer," he concludes in his note to investors. Johnson keeps a Sell rating on Tesla shares. - 08/20/18
- MSCO
08/20/18
NO CHANGETarget $15
MSCO
Overweight Ford risks high, but so is potential reward, says Morgan Stanley Morgan Stanley analyst Adam Jonas believes Ford announcing plans to spend $11B on restructuring and then canceling its investor day may have may have the unintended consequence of raising expectations for a "big bang" of action. While acknowledging the wide range of potential outcomes, Jonas has an estimate for how Ford could recognize its planned $11B in restructuring charges over a 3-5 year period to achieve annual cost reductions of about $4B, giving it a payback period of just under 3 years that would "usually [be] a very good use of capital" by automotive standards, he tells investors. Jonas maintains an Overweight rating on Ford with a $15 price target, contending that the "risks are high, but so is the potential reward." - 09/10/18
- SBSH
09/10/18
NO CHANGETarget $9.9
SBSH
Neutral Ford price target lowered to $9.90 from $10.50 at Citi Citi analyst Itay Michaeli lowered his price target for Ford (F) to $9.90 to reflect restructuring-related calls on cash. The analyst keeps a Neutral rating on the shares and continues to maintain his preference for General Motors (GM). Ford faces both fundamental and perception problems, whereas GM just faces the latter, Michaeli tells investors in a research note. While the company must deal with some legitimate China and trade headwinds, the degree of erosion that's implied by the pullback in the shares is overdone, the analyst contends. - $33.31
-0.89 (-2.60%) - 09/11/18
- GSCO
09/11/18
INITIATIONTarget $36
GSCO
Neutral General Motors reinstated with a Neutral at Goldman Sachs Goldman Sachs analyst David Tamberrino reinstated coverage of General Motors with a Neutral rating and $36 price target. Before going Not Rated on the name, Goldman had a Sell rating on the shares. The path forward for the shares is "somewhat murky" with a "more challenged" backdrop in North America and growing concerns about the potential for China joint venture income to see further pressure, Tamberrino tells investors in a research note. The analyst sees positives from GM's pickup truck refresh and Korea restructuring accruing in 2019, but still expects a "downward trajectory" to earnings and free cash flow next year. However, he believes the market is prepping for a flat-to-down earnings trajectory and views the stock's risk/reward as balanced at current levels. - 09/11/18
- RBCM
09/11/18
NO CHANGETarget $49
RBCM
Outperform General Motors valuation reflects 'low expectations', says RBC Capital RBC Capital analyst Joseph Spak kept his Outperform rating and $49 price target on General Motors after hosting meetings with its CEO Mary Barra and CFO Dhivya Suryadevara. The analyst says he remains positive on the company's execution, adding that while investors are focused on China and the direction of earnings in FY19, he believes that the market expectations are already "very low" with forward valuation multiple ex-Cruise and ex-cash at just over 3.5-times earnings. Spak also cites the positives for General Motors from the " recovering volume on light-duty pickups", cost savings, and expectations of strong performance in the mid-size CUV class. - 09/11/18
On The Fly: Top five analyst initiations Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Krystal Biotech (KRYS) initiated with an Overweight at Cantor Fitzgerald. 2. Melinta Therapeutics (MLNT) initiated with a Buy at H.C. Wainwright and Jefferies. 3. Burlington Stores (BURL) initiated with an Overweight at Barclays. 4. General Motors (GM) reinstated with a Neutral at Goldman Sachs. 5. SailPoint (SAIL) initiated with a Market Perform at Northland. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here. - $108.72
-2.11 (-1.90%) - 08/14/18
- EVER
BodyArmor stake positive for Coca-Cola, negative for Pepsi, says Evercore Evercore ISI analyst Robert Ottenstein views Coca-Cola's stake in BodyArmor as a "clear positive" for the company and a "clear negative" for both PepsiCo (PEP) and Keurig Dr Pepper (KDP). Pepsi's Gatorade product is most at risk with Coca-Cola taking a stake in BodyArmor, and Keurig Dr Pepper "losses distribution of the product and any path to ownership it might have enjoyed," Ottenstein tells investors in a research note. - 07/24/18
- RHCO
07/24/18
NO CHANGETarget $110
RHCO
Hold PepsiCo price target raised to $110 from $105 at SunTrust SunTrust analyst William Chappell raised his price target on PepsiCo to $110 to account for gains related to the impact of refranchising transactions, which he expects to support the company's high-single-digit EPS growth trend going forward. The analyst also keeps his Hold rating on PepsiCo as the stock is "fairly valued", with the company's Beverage business trading in line with peers and the Food business trading at the high end of its large-cap snack food peer range. - 09/13/18
- GUGG
09/13/18
INITIATIONGUGG
Neutral PepsiCo initiated with a Neutral at Guggenheim - 07/23/18
- JEFF
07/23/18
NO CHANGETarget $107
JEFF
Hold Jefferies sees risk of near-term downside in PepsiCo shares Jefferies analyst Kevin Grundy sees potential near-term downside in shares of PepsiCo. Despite fundamental challenges and weak earnings quality, PepsiCo's "relative multiple remains elevated," Grundy tells investors in a research note. The analyst is "negatively biased" toward PepsiCo and reiterates a Hold rating on the shares with a $107 price target. - $86.45
0.62 (0.72%) - 09/21/18
- RBCM
09/21/18
NO CHANGETarget $115
RBCM
Outperform Exxon Mobil long term investment visibility improving, says RBC Capital RBC Capital analyst Biraj Borkhataria kept his Outperform rating and $115 price target on Exxon Mobil after meeting with its investor relations VP at the company's recent non deal roadshow. The analyst notes that the discussions focused on Exxon Mobil's accelerating rig activity in the Permian and Guyana with little impact observed from wider differentials. Borkhataria also believes that stock buybacks may begin as soon as early 2019, ahead of expectations, adding that the Exxon Mobil stock remains one of his "top ideas for longer term". - 09/28/18
- OPCO
09/28/18
NO CHANGETarget $89
OPCO
Outperform Teladoc price target raised to $89 from $68 at Oppenheimer Oppenheimer analyst Mohan Naidu reiterated an Outperform rating on Teledoc and raised his price target to $89 from $68 following the company's analyst day, which highlighted its new deal flow, including relationships with Centene (CNC) and Exxon (XOM), and a very strong pipeline. The recent CMS telehealth proposal makes Medicare a 2020 tailwind, Naidu tells investors in a research note, and says he has gained confidence that Teladoc's competitive barriers include its broad platform and its network of physicians that quickly matches supply and demand. - 09/11/18
- BREN
09/11/18
INITIATIONTarget $84
BREN
Hold Exxon Mobil initiated with a Hold at Berenberg Berenberg analyst Henry Tarr started Exxon Mobil with a Hold rating and $84 price target. - 09/07/18
- RHCO
09/07/18
UPGRADETarget $25
RHCO
Buy Centennial Resource Development upgraded to Buy at SunTrust on output prospects As reported earlier, SunTrust analyst Neal Dingmann upgraded Centennial Resource Development (CDEV) to Buy from Hold and raised his price target to $25 from $20. The analyst cites the company's "operational strides" to ensure that its 2020 production goal is achieved while also noting its "pricing diversification" efforts through its latest crude agreement with Exxon Mobil (XOM) as well as its position of an "early mover" among Permian E&Ps on the gas side. Dingmann advises that investors take advantage of the current "opportune entry point" given Centennial Resource Development's "below peer valuation". - $31.40
2.245 (7.70%) - 09/17/18
- GUGG
09/17/18
INITIATIONTarget $75
GUGG
Buy Clovis initiated with a Buy at Guggenheim Target $75. - 09/24/18
- LEER
09/24/18
INITIATIONTarget $30
LEER
Market Perform Clovis initiated with a Market Perform at Leerink Leerink analyst Andrew Berens started Clovis Oncology with a Market Perform rating and $30 price target. - 09/21/18
- JPMS
09/21/18
NO CHANGETarget $71
JPMS
Overweight Clovis price target lowered to $71 from $87 at JPMorgan JPMorgan analyst Cory Kasimov lowered his price target for Clovis Oncology to $71 after "reigning in" his ovarian expectations but keeps an Overweight rating on the shares. With the European Society of Medical Oncology meeting coming up in October, Kasimov is previewing the first look at data from Clovis's Triton-2 study in prostate cancer. The analyst is "quite confident" that the company's PARP inhibitor rucaparib should produce response rates that are well above chemotherapy and anti-androgens, at least in third line BRCA positive patients. He views the Triton-2 update as an important event for Clovis and believes "promising results could represent a step towards restoring more favorable sentiment." A response rate of at least 30% is the lower bar for share appreciation, Kasimov tells investors in a research note. He keeps an Overweight rating on Clovis. - 10/02/18
- JPMS
10/02/18
NO CHANGEJPMS
Overweight JPMorgan increasingly confident in Clovis Oncology's rucaparib JPMorgan analyst Cory Kasimov is encouraged by Clovis Oncology's announcement this morning that rucaparib received breakthrough designation from the FDA for the third line treatment of patients with BRCA mutated metastatic castrate-resistant prostate cancer on the basis of data from the Triton-2 study. The analyst says the news further increases his confidence in the potential for rucaparib to produce response rates that are meaningfully better than currently available options. His model implies $9 per share for prostate, assuming a 55% probability of success and $450M in peak unadjusted sales. Kasimov keeps an Overweight rating on Clovis, which is up 11%, or $3.33, to $32.47 in morning trading. IGC India Globalization Capital - $13.13
4.11 (45.57%) - $8.71
-1.95 (-18.29%) - 02/06/18
- RILY
02/06/18
INITIATIONTarget $22
RILY
Buy Ring Energy initiated with a Buy at B. Riley FBR B. Riley FBR analyst Rehan Rashid started Ring Energy with a Buy rating and $22 price target. - 10/02/18
- GHSC
10/02/18
DOWNGRADEGHSC
Neutral Ring Energy downgraded to Neutral from Buy at Seaport Global Seaport Global analyst John Aschenbeck downgraded Ring Energy to Neutral and cut its price target to $12 from $20. The analyst has looked at state data obtained from DrillingInfo and come to the conclusion that Ring's 2018 hz. San Andres completions have been underperforming older vintages by approximately 25%, and his prior type curve estimates by 34%. - 03/28/18
- ROTH
03/28/18
NO CHANGETarget $50.5
ROTH
Buy Concho acquisition of RSP may be catalyst for Permian consolidation, says Roth Capital Roth Capital analyst John White notes that Concho Resources (CXO) and RSP Permian announced they have entered into a definitive agreement under which the former will acquire the latter in an all-stock transaction valued at approximately $9.5B, inclusive of RSP's net debt. The analyst believes this transaction could potentially be a catalyst for additional consolidation in the Permian Basin. White points out that there are a large number of small and mid-cap operators active in the basin, including Approach Resources (AREX), Callon Petroleum (CPE), Diamondback Energy (FANG), Earthstone Energy (ESTE), Halcon Resources (HK), Laredo Petroleum (LPI), Matador (MTDR), Parsley Energy (PE), Ring Energy (REI). The analyst has a Buy rating and $50.50 price target on RSP Permian's shares. - 06/14/18
- IMPC
06/14/18
NO CHANGEIMPC
Outperform Imperial Capital sees attractive valuations for Permian names The market has overreacted to the "inevitable traffic jams and competition for outbound transportation" taking place in the Permian region, Imperial Capital analysts Irene Haas and Jason Wangler tells investors in a research note. Following conversations with industry participants in both the upstream and midstream arenas of the Permian Region, the analysts believes relief for oil could materialize in early 2019. They sees a "handful of high quality Permian names at attractive valuations," including Diamondback Energy (FANG), Resolute Energy (REN), Ring Energy (REI), Callon Petroleum (CPE), Matador Resources and PDC Energy (PDCE). - $28.90
-15.8 (-35.35%) - 09/25/18
- JPMS
09/25/18
NO CHANGETarget $36
JPMS
Neutral Stitch Fix price target raised to $36 from $26 at JPMorgan JPMorgan analyst Doug Anmuth raised his price target for Stitch Fix to $36 but keeps a Neutral rating on the shares. The stock is up 110% since the company's fiscal Q3 earnings report on June 7, which the analyst attributes to a widely held view that management's Q4 guidance is conservative and consensus fiscal 2019 estimates are too low. He agrees that the Q4 guidance has upside potential. However, while Anmuth remains confident in Stitch Fix's market opportunity, he like to see another quarter or two of 25%-plus revenue growth and better margin visibility before getting more constructive on the name. - 09/20/18
Fly Intel: Today's top analyst calls on Wall Street Check out today's top analyst calls from around Wall Street, compiled by The Fly. BAIRD UPGRADES CATERPILLAR TO OUTPERFORM: Baird analyst Mig Dobre upgraded Caterpillar (CAT) to Outperform from Neutral. The analyst believes demand growth should continue into 2019. While some markets like China are close to peak, most of its demand is still at or below mid-cycle levels, said Dobre, who raised his price target to $191 from $155 on Caterpillar shares. Caterpiller is up 1.5% in late morning trading. PIPER CUTS STITCH FIX TO NEUTRAL: Piper Jaffray analyst Erinn Murphy downgraded Stitch Fix (SFIX) to Neutral while raising her price target for the shares to $43 from $29. The analyst cited valuation for the downgrade. With shares nearing $50, market expectations do not provide any margin of error, Murphy said. She believes the "smallest hint" of pressure could be a significant negative catalyst for the stock. Further, the analyst notes that Amazon's (AMZN) Prime Wardrobe is now advertising in key NFL slots and that the company is testing a personalized recommendation service for certain categories. In late morning trading, Stitch Fix is lower by over 13%. COWEN CUTS SKECHERS TO MARKET PERFORM: Cowen analyst John Kernan downgraded Skechers (SKX) to Market Perform from Outperform citing growing inventory levels, particularly as foreign exchange headwinds in key markets build. He also believes consensus forecasts for operating expansion are too optimistic. Kernan lowered his price target to $28 from $32 on Skechers shares, which are down 4.7% in late morning trading. JPMORGAN CUTS GE'S PRICE TARGET: JPMorgan analyst Stephen Tusa lowered his price target for General Electric (GE) to $10 from $11 and kept an Underweight rating on the shares. The impact on "asset value" from a failure at GE's U.S. H-frame launch customer, while tough to estimate, represents a negative development for a company that has little wiggle room for more "shoes to drop," Tusa said. MORGAN STANLEY POSITIVE ON APPLE IPHONE DUAL-SIM ADDITION: In EMEA and Asia, smartphones with dual-SIM capabilities have become the status quo, noted Morgan Stanley analyst Katy Huberty, who believes that Apple adding dual-SIM to the new iPhones is an underappreciated feature with the potential to drive upside to shipments in FY19. Huberty kept an Overweight rating and $247 price target on Apple shares. - 10/02/18
- STFL
10/02/18
NO CHANGETarget $30
STFL
Hold Stitch Fix price target raised to $30 after 'mixed' Q4 at Stifel Stifel analyst Scott Devitt said Stitch Fix reported "mixed" Q4 results with adjusted EBITDA above consensus and revenue growth modestly below analysts' expectations. While he supports management's selected areas of investment, Devitt believe the stocks' current valuation reflects the company's attractive growth opportunities. He raised his price target on Stitch Fix shares to $30 from $26 following the earnings report and maintains a Hold rating on the stock. - 10/02/18
- PIPR
10/02/18
NO CHANGETarget $31
PIPR
Overweight Stitch Fix price target lowered to $31 from $43 at Piper Jaffray Piper Jaffray analyst Erinn Murphy lowered her price target for Stitch Fix to $31 saying the outlook for Q1 suggests the company's core growth is moderating. The analyst remains on the sidelines with respect to the shares and keeps a Neutral rating on Stitch Fix. |